HIV/AIDS合并病毒性肝炎的临床研究  

Clinical study of HIV/AIDS co-infection with hepatitis

作　　者：买买提艾力.吾布力 潘珂君[1] 孙晓风[1] 鲁晓擘[1] 依巴古力[1] 张跃新[1] 

机构地区：[1]新疆医科大学第一附属医院感染性疾病中心,新疆乌鲁木齐830011

出　　处：《新疆医科大学学报》2011年第8期840-842,共3页Journal of Xinjiang Medical University

基　　金：科技部"十一五"重大专项(2009ZX10001-019)

摘　　要：目的了解HIV/AIDS合并感染病毒性肝炎患者的基本情况。方法对新疆医科大学第一附属医院感染性疾病中心从2001～2010年诊治的395例HIV/AIDS患者的临床资料,通过构成比等方法对所有病例进行回顾性分析。结果合并感染病毒性肝炎的病例占34.17%,其中3.29%的病例为HIV/HBV/HCV的混合感染。感染途径以静脉药瘾为主;肝功能异常的病例为44.89%;54.07%的病例HBV-DNA/HCV-RNA检测为阳性。结论 HIV/AIDS合并病毒性肝炎的传播途径以静脉药瘾为主,可出现各级的肝功能损害,但无明显差异。Objective To summary the basic clinical situation on Human immunoddficiency virus（HIV）/acquired immunodeficiency syndrome（AIDS） patients with viral hepatitis.MethodsFrom the year 2001 to 2010 in our hospital,395 HIV/AIDS patients,the clinical data was summarized through the methods constitute a retrospective analysis of all cases.ResultsCo-infection with viral hepatitis accounted for 34.17%,3.29% of the cases with the HIV/Hepatitis B virus（HBV）/Hepatitis C virus（HCV） co-infection.The main route was intravenous drug.Cases of abnormal liver function were 44.89%.54.07% cases HBV-DNA/HCV-RNA were tested positive.ConclusionIn this study,hepatitis cases accounted for 34.17%;Mainly route of transmission was by intravenous drug users;Liver damage can occur at all levels,but no significant difference.

关 键 词：HIV HBV HCV 混合感染 

分 类 号：R512.6[医药卫生—内科学]